BGSF Q2 revenue falls on lower billable hours
BGSF Q2 revenue falls on lower billable hours
Overview
US workforce solutions provider's fiscal Q2 revenue declined yr/yr due to lower billable hours
Adjusted EPS loss for fiscal Q2 narrowed from prior year
Company reduced costs and streamlined operations following end of transition services agreement
Outlook
Company expects to benefit from cost reductions and operational streamlining in Q3
BGSF anticipates its PropTech services strategy will build a solid sales funnel for the coming year
Company says Q3 is seasonally its strongest quarter
Result Drivers
LOWER BILLABLE HOURS - Co said Q2 revenue decline was driven by fewer billable hours compared to prior year
COST REDUCTIONS - Co said decrease in net loss was primarily driven by reduction in selling, general, and administrative expenses
ORGANIZATIONAL STREAMLINING - Co said it continued to streamline operations in both front office and back office following end of transition services agreement with INSPYR
Company press release: ID:nGNXb1rsQc
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue |
| $22.31 mln |
|
Q2 Adjusted Loss Per Share |
| $0.02 |
|
Reuters Recommended Reads
Aug 5 - Barrett Business Q2 revenue slightly misses estimates on softness in client hiring
Aug 4 - TrueBlue Q2 adjusted EPS beats estimates as on-demand business returns to growth
Aug 3 - Germany's Amadeus Fire H1 revenue falls on weak personnel services demand; EBITA drops
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on BGSF
See all newsBGSF Q2 revenue falls on lower billable hours
BGSF Q1 revenue flat, adjusted EPS loss narrows
U.S. STOCKS ON THE MOVE-Vaccine makers, NextDecade, Alaska Air Group
U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Cocrystal Pharma, Prenetics Global
Bgsf Inc Reports Results For The Quarter Ended June 30: Earnings Summary